"What" Series

What are the effects of ubiquitination on protein degradation?

2 January 2024
2 min read

Ubiquitination is a process that involves adding a protein called ubiquitin to a substrate protein. This process plays a vital role in regulating various cellular processes, including protein degradation.

In terms of protein degradation, ubiquitination acts as a key signal for the cell's protein degradation machinery. When proteins are tagged with ubiquitin, it acts as a beacon, signaling the 26S proteasome (the cellular machine responsible for degrading proteins) to recognize the marked protein and degrade it.

The degradation of proteins through this ubiquitin-proteasome pathway allows cells to regulate the concentration of particular proteins, eliminating those that are damaged, misfolded, or no longer necessary for the cell's function.

Notably, the degradation of proteins via the ubiquitin-proteasome pathway is an ATP-dependent process, meaning it requires energy input from the cell.

Thus, the effect of ubiquitination on protein degradation is predominantly that of a marking system, identifying specific proteins for degradation and consequently controlling protein homeostasis, quality control, cell cycle progression, and many other critical physiological processes.

Failure or malfunctioning of this pathway has been associated with several diseases, including cancer, neurodegenerative disorders, and immune system abnormalities, highlighting the crucial role ubiquitination plays in maintaining cellular health and function.

Demystifying H2 receptor antagonists: A Comprehensive Guide and How to Keep Up with the Latest Developments
Demystifying H2 receptor antagonists: A Comprehensive Guide and How to Keep Up with the Latest Developments
2 January 2024
H2 receptor antagonists are drugs that inhibit histamine action in the stomach, reducing acid production.
Read →
Mineralys Therapeutics Announces First Patient Dosed in Start-HTN, Its Second Key Trial of Lorundrostat for Hypertension Control
Latest Hotspot
3 min read
Mineralys Therapeutics Announces First Patient Dosed in Start-HTN, Its Second Key Trial of Lorundrostat for Hypertension Control
2 January 2024
Mineralys Therapeutics Reports Initial Participant Receives Dose in Start-HTN, Their Second Major Study of Lorundrostat Aimed at Hypertension Management.
Read →
Jazz Pharmaceuticals Releases Information on Stage 2 Research for Experimental JZP150 in Adults Suffering from PTSD
Latest Hotspot
3 min read
Jazz Pharmaceuticals Releases Information on Stage 2 Research for Experimental JZP150 in Adults Suffering from PTSD
2 January 2024
Jazz Pharmaceuticals plc announced early results from its Phase 2 trial evaluating the efficacy and safety of JZP150, a selective FAAH enzyme inhibitor, in adults with PTSD.
Read →
How does pH affect drug delivery?
Knowledge Base
3 min read
How does pH affect drug delivery?
2 January 2024
Drug delivery can be significantly affected by the pH of the environment in which it occurs.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.